Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome

被引:3
|
作者
Moin, Abu Saleh Md [1 ]
Nandakumar, Manjula [1 ]
Sathyapalan, Thozhukat [2 ]
Atkin, Stephen L. [3 ]
Butler, Alexandra E. [1 ]
机构
[1] Hamad Bin Khalifa Univ HBKU, Qatar Biomed Res Inst QBRI, Qatar Fdn, Diabet Res Ctr DRC, POB 34110, Doha, Qatar
[2] Hull York Med Sch, Acad Endocrinol Diabet & Metab, Kingston Upon Hull, N Humberside, England
[3] Royal Coll Surg Ireland Bahrain, Adliya, Bahrain
关键词
Biomarkers; Polycystic ovary syndrome; COVID-19; SARS-CoV-2; Platelet degranulation; Coagulation factors;
D O I
10.1186/s12967-021-02723-7
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Laboratory Biomarkers in the Management of Patients With COVID-19
    Weidmann, Maxwell D.
    Ofori, Kenneth
    Rai, Alex J.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 155 (03) : 333 - 342
  • [32] Validation of mitochondrial biomarkers and immune dynamics in polycystic ovary syndrome
    Shen, Hui-Hui
    Zhang, Yang-Yang
    Wang, Xuan-Yu
    Li, Meng-Ying
    Liu, Zhen-Xing
    Wang, Ying
    Ye, Jiang-Feng
    Wu, Hui-Hua
    Li, Ming-Qing
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2024, 91 (04)
  • [33] Correlation of lymphocyte subsets and inflammatory biomarkers with disease severity in COVID-19 patients
    Abbas, Khawar
    Musharraf, Wajiha
    Zafar, Mirza Naqi
    Lal, Jawahar
    Dodani, Sunil
    Rizvi, Syed Adibul Hasan
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2024, 74 (01) : 78 - 83
  • [34] Lipidomic biomarkers in polycystic ovary syndrome: An overview
    Ilie, Ioana Rada Popa
    Herdean, Alina Maria
    Herdean, Andrei Ioan
    Georgescu, Carmen Emanuela
    ANNALES D ENDOCRINOLOGIE, 2023, 84 (01) : 69 - 80
  • [35] Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19
    Xue, Guohui
    Gan, Xing
    Wu, Zhiqiang
    Xie, Dan
    Xiong, Yan
    Hua, Lin
    Zhou, Bing
    Zhou, Nanjin
    Xiang, Jie
    Li, Junming
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 89
  • [36] Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome
    Nandakumar, Manjula
    Das, Priya
    Sathyapalan, Thozhukat
    Butler, Alexandra E.
    Atkin, Stephen L.
    BIOMOLECULES, 2025, 15 (01)
  • [37] Preliminary Results for Personalized Therapy in Pregnant Women with Polycystic Ovary Syndrome During the COVID-19 Pandemic
    Małgorzata Jerzak
    Monika Szafarowska
    Archivum Immunologiae et Therapiae Experimentalis, 2022, 70
  • [38] Preliminary Results for Personalized Therapy in Pregnant Women with Polycystic Ovary Syndrome During the COVID-19 Pandemic
    Jerzak, Malgorzata
    Szafarowska, Monika
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2022, 70 (01)
  • [39] Predictive Biomarkers of COVID-19 Severity in SARS-CoV-2 Infected Patients with Obesity and Metabolic Syndrome
    Perpinan, Carles
    Bertran, Laia
    Terra, Ximena
    Aguilar, Carmen
    Lopez-Dupla, Miguel
    Alibalic, Ajla
    Riesco, David
    Camaron, Javier
    Perrone, Francesco
    Rull, Anna
    Reverte, Laia
    Yeregui, Elena
    Marti, Anna
    Vidal, Francesc
    Auguet, Teresa
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (03):
  • [40] The Severity of COVID-19 in Diabetes Patients
    Danao, Kishor
    Rokde, Vijayshri
    Bali, Nikhil
    Mahajan, Ujwala
    CURRENT DIABETES REVIEWS, 2023, 19 (05)